Mackay Shields LLC Charles River Laboratories International, Inc. Transaction History

Mackay Shields LLC

$499 Million
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$204.13 - $302.4 $1.48 Million - $2.19 Million	-7,251 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $73,331 - $103,925	-287 Reduced 3.81%	7,251 $2.06 Million
Q4 2021 Feb 04, 2022	SELL	$351.38 - $448.68 $53,409 - $68,199	-152 Reduced 1.98%	7,538 $2.84 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $169,551 - $208,526	-455 Reduced 5.59%	7,690 $3.17 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $6.97 Million - $8.81 Million	-23,706 Reduced 74.43%	8,145 $3.01 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $8.13 Million - $9.75 Million	-32,568 Reduced 50.56%	31,851 $9.23 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $1.24 Million - $1.41 Million	-5,600 Reduced 8.0%	64,419 $16.1 Million
Q3 2020 Nov 04, 2020	SELL	$175.56 - $226.45 $26,158 - $33,741	-149 Reduced 0.21%	70,019 $15.9 Million
Q2 2020 Jul 31, 2020	SELL	$118.84 - $189.72 $3.84 Million - $6.13 Million	-32,312 Reduced 31.53%	70,168 $12.2 Million
Q1 2020 May 08, 2020	SELL	$98.9 - $178.34 $1.85 Million - $3.33 Million	-18,678 Reduced 15.42%	102,480 $12.9 Million
Q4 2019 Feb 11, 2020	BUY	$126.05 - $152.76 $6.53 Million - $7.92 Million	51,844 Added 74.8%	121,158 $18.5 Million
Q3 2019 Nov 01, 2019	BUY	$125.07 - $143.67 $2.46 Million - $2.83 Million	19,679 Added 39.65%	69,314 $9.18 Million
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $9.04 Million - $10.9 Million	-73,278 Reduced 59.62%	49,635 $7.04 Million
Q1 2019 May 13, 2019	SELL	$104.82 - $146.73 $187,418 - $262,353	-1,788 Reduced 1.43%	122,913 $17.9 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $13.1 Million - $17.1 Million	124,701 New	124,701 $14.1 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $5.18 Million - $6.21 Million	-46,182 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$102.37 - $117.25 $3.46 Million - $3.96 Million	33,781 Added 272.41%	46,182 $5.18 Million
Q1 2018 May 03, 2018	BUY	$98.19 - $115.2 $1.22 Million - $1.43 Million	12,401 New	12,401 $1.32 Million

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$1.02 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$841 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

4.08M
Shares

$674 Million
0.14% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$361 Million
0.02% of portfolio
Allspring Global Investments Holdings, LLC

1.81M
Shares

$299 Million
0.56% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account